Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
5.15
-0.12 (-2.28%)
Dec 4, 2025, 4:00 PM EST - Market closed
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $9.89 million as of December 5, 2025. Its market cap has decreased by -54.33% in one year.
Market Cap
9.89M
Enterprise Value
1.87M
1-Year Change
-54.33%
Ranking
Category
Stock Price
$5.15
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $9.89M, a decrease of -98.57%. That is a compound annual growth rate of -58.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 10.12M | -50.61% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | 690.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |